Fusion Biopsy Market Thrives as Healthcare Providers Prioritize Early and Accurate Diagnosis
📢 Executive Summary The global Fusion Biopsy Market was valued at USD 736.69 million in 2024 and is projected to reach USD 1,677.18 million by 2034, growing at a compound annual growth rate (CAGR) of 8.6% between 2025 and 2034. This growth trajectory is underpinned by the increasing prevalence of prostate cancer, growing demand for minimally invasive procedures, and the integration of...
0 Commenti 0 condivisioni